Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12296
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMårtensson, Johanen
dc.contributor.authorBellomo, Rinaldoen
dc.date.accessioned2015-05-16T01:57:33Z
dc.date.available2015-05-16T01:57:33Z
dc.date.issued2014-08-01en
dc.identifier.citationCurrent Opinion in Critical Care; 20(4): 451-9en
dc.identifier.govdoc24999794en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12296en
dc.description.abstractTo describe the effect of ageing on kidney function and to summarize the benefits of advocated measures to prevent perioperative acute kidney injury (AKI) in elderly patients.Given a reduced renal reserve and the burden of comorbidities, the senescent kidney is susceptible to develop perioperative AKI and is less able to recover when injury occurs. Current evidence suggests that preoperative statin therapy, tight glycemic control or urine alkalinization with bicarbonate do not protect the kidneys from harm. The theoretical kidney protective effect of preoperative aspirin therapy or renal vasodilatation with atrial natriuretic peptide or fenoldopam is only supported by low-quality evidence that needs further evaluation. Although questions regarding the amount and timing of fluid resuscitation during surgery are seeking answers in ongoing multicenter studies, the harmful effect of hydroxyethyl starches (HES) and hyperchloremic solutions is now surrounded by strong evidence.The future increase in elderly patients being exposed to surgery calls for improved perioperative management to prevent collaterally increased AKI. Although pharmacological therapies aiming to protect the kidneys from harm are under evaluation, hemodynamic optimization and avoidance of nephrotoxic drugs, including HES and hyperchloremic solutions, are critical for the elderly perioperative patient.en
dc.language.isoenen
dc.subject.otherAcute Kidney Injury.prevention & controlen
dc.subject.otherAgeden
dc.subject.otherAging.physiologyen
dc.subject.otherAspirin.therapeutic useen
dc.subject.otherHumansen
dc.subject.otherKidney.physiopathologyen
dc.subject.otherPostoperative Careen
dc.subject.otherPostoperative Complications.prevention & controlen
dc.titlePrevention of renal dysfunction in postoperative elderly patients.en
dc.typeJournal Articleen
dc.identifier.journaltitleCurrent opinion in critical careen
dc.identifier.affiliationDepartment of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care Medicine, Karolinska Institutet, Stockholm, Sweden bDepartment of Intensive Care, Austin Hospital, Melbourne cDepartment of Epidemiology and Preventive Medicine, Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1097/MCC.0000000000000107en
dc.description.pages451-9en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/24999794en
dc.type.austinJournal Articleen
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Jan 29, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.